
Juliet Caroline Switzer
Examiner (ID: 16746, Phone: (571)272-0753 , Office: P/1634 )
| Most Active Art Unit | 1634 |
| Art Unit(s) | 1634, 1655, 1682 |
| Total Applications | 1159 |
| Issued Applications | 375 |
| Pending Applications | 219 |
| Abandoned Applications | 588 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16177280
[patent_doc_number] => 20200224248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => HIGHLY POLYMORPHIC AND MODULAR EXTRAGENIC (H.P.M.E.) MARKERS WITHIN SPECIFIC TAXA OF MICROORGANISMS AND USE THEREOF FOR THEIR DIFFERENTIATION, IDENTIFICATION AND QUANTIFICATION
[patent_app_type] => utility
[patent_app_number] => 16/319396
[patent_app_country] => US
[patent_app_date] => 2017-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19785
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16319396
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/319396 | HIGHLY POLYMORPHIC AND MODULAR EXTRAGENIC (H.P.M.E.) MARKERS WITHIN SPECIFIC TAXA OF MICROORGANISMS AND USE THEREOF FOR THEIR DIFFERENTIATION, IDENTIFICATION AND QUANTIFICATION | Jul 23, 2017 | Abandoned |
Array
(
[id] => 14963787
[patent_doc_number] => 20190309372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => METHODS AND COMPOSITIONS FOR DETECTING ESOPHAGEAL NEOPLASIAS AND/OR METAPLASIAS IN THE ESOPHAGUS
[patent_app_type] => utility
[patent_app_number] => 16/315405
[patent_app_country] => US
[patent_app_date] => 2017-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48947
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -53
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315405
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/315405 | Methods and compositions for detecting esophageal neoplasias and/or metaplasias in the esophagus | Jul 4, 2017 | Issued |
Array
(
[id] => 15869049
[patent_doc_number] => 20200141928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => METHOD FOR RNA TAGGING AND ANALYSIS ON SINGLE CELL
[patent_app_type] => utility
[patent_app_number] => 16/305071
[patent_app_country] => US
[patent_app_date] => 2017-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1882
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16305071
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/305071 | METHOD FOR RNA TAGGING AND ANALYSIS ON SINGLE CELL | Jun 21, 2017 | Pending |
Array
(
[id] => 18399505
[patent_doc_number] => 11661632
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-30
[patent_title] => Compositions and methods for diagnosing lung cancers using gene expression profiles
[patent_app_type] => utility
[patent_app_number] => 16/312036
[patent_app_country] => US
[patent_app_date] => 2017-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 29084
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16312036
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/312036 | Compositions and methods for diagnosing lung cancers using gene expression profiles | Jun 20, 2017 | Issued |
Array
(
[id] => 12682180
[patent_doc_number] => 20180119226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => Methods of Detecting Signatures of Disease or Conditions in Bodily Fluids
[patent_app_type] => utility
[patent_app_number] => 15/617577
[patent_app_country] => US
[patent_app_date] => 2017-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19586
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15617577
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/617577 | Methods of detecting signatures of disease or conditions in bodily fluids | Jun 7, 2017 | Issued |
Array
(
[id] => 12092859
[patent_doc_number] => 20170349953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-07
[patent_title] => 'NOVEL MUTATIONS IN ANAPLASTIC LYMPHOMA KINASE PREDICTING RESPONSE TO ALK INHIBITOR THERAPY IN LUNG CANCER PATIENTS'
[patent_app_type] => utility
[patent_app_number] => 15/611612
[patent_app_country] => US
[patent_app_date] => 2017-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10310
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15611612
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/611612 | NOVEL MUTATIONS IN ANAPLASTIC LYMPHOMA KINASE PREDICTING RESPONSE TO ALK INHIBITOR THERAPY IN LUNG CANCER PATIENTS | May 31, 2017 | Abandoned |
Array
(
[id] => 12031180
[patent_doc_number] => 20170321278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'DETECTION AND TREATMENT OF POLYCYSTIC KIDNEY DISEASE'
[patent_app_type] => utility
[patent_app_number] => 15/601804
[patent_app_country] => US
[patent_app_date] => 2017-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 39941
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15601804
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/601804 | DETECTION AND TREATMENT OF POLYCYSTIC KIDNEY DISEASE | May 21, 2017 | Abandoned |
Array
(
[id] => 14375791
[patent_doc_number] => 20190161808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-30
[patent_title] => METHOD FOR PREDICTING PROGNOSIS OF BREAST CANCER PATIENTS BY USING GENE DELETIONS
[patent_app_type] => utility
[patent_app_number] => 16/300927
[patent_app_country] => US
[patent_app_date] => 2017-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9997
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16300927
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/300927 | METHOD FOR PREDICTING PROGNOSIS OF BREAST CANCER PATIENTS BY USING GENE DELETIONS | May 11, 2017 | Abandoned |
Array
(
[id] => 15681955
[patent_doc_number] => 20200095641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => MEANS AND METHODS FOR ANTI-VEGF THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/095197
[patent_app_country] => US
[patent_app_date] => 2017-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33330
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095197
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/095197 | MEANS AND METHODS FOR ANTI-VEGF THERAPY | Apr 20, 2017 | Abandoned |
Array
(
[id] => 12031175
[patent_doc_number] => 20170321274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'EPIGENETIC MARKERS OF PLURIPOTENCY'
[patent_app_type] => utility
[patent_app_number] => 15/490101
[patent_app_country] => US
[patent_app_date] => 2017-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13810
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15490101
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/490101 | EPIGENETIC MARKERS OF PLURIPOTENCY | Apr 17, 2017 | Abandoned |
Array
(
[id] => 11936817
[patent_doc_number] => 20170240967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'DISEASE SUSCEPTIBILITY'
[patent_app_type] => utility
[patent_app_number] => 15/473464
[patent_app_country] => US
[patent_app_date] => 2017-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 48703
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15473464
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/473464 | DISEASE SUSCEPTIBILITY | Mar 28, 2017 | Abandoned |
Array
(
[id] => 16269199
[patent_doc_number] => 20200270686
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => EYE DISEASE BIOMARKER
[patent_app_type] => utility
[patent_app_number] => 16/089114
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10636
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16089114
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/089114 | EYE DISEASE BIOMARKER | Mar 27, 2017 | Abandoned |
Array
(
[id] => 11729695
[patent_doc_number] => 20170191137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-06
[patent_title] => 'Method For Predicting Effectiveness Of Angiogenesis Inhibitor'
[patent_app_type] => utility
[patent_app_number] => 15/460629
[patent_app_country] => US
[patent_app_date] => 2017-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 27229
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15460629
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/460629 | Method For Predicting Effectiveness Of Angiogenesis Inhibitor | Mar 15, 2017 | Abandoned |
Array
(
[id] => 19969904
[patent_doc_number] => 12338497
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-24
[patent_title] => Analyzing RNA for diagnosing infection type
[patent_app_type] => utility
[patent_app_number] => 16/081069
[patent_app_country] => US
[patent_app_date] => 2017-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 50547
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16081069
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/081069 | Analyzing RNA for diagnosing infection type | Mar 1, 2017 | Issued |
Array
(
[id] => 11742768
[patent_doc_number] => 20170196840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'METHODS AND COMPOSITIONS FOR DETERMINING RESISTANCE TO ANDROGEN RECEPTOR THERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/446341
[patent_app_country] => US
[patent_app_date] => 2017-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 44722
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15446341
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/446341 | METHODS AND COMPOSITIONS FOR DETERMINING RESISTANCE TO ANDROGEN RECEPTOR THERAPY | Feb 28, 2017 | Abandoned |
Array
(
[id] => 12368115
[patent_doc_number] => 09957574
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-01
[patent_title] => BCR-ABL1 splice variants and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/429640
[patent_app_country] => US
[patent_app_date] => 2017-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 7
[patent_no_of_words] => 14452
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15429640
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/429640 | BCR-ABL1 splice variants and uses thereof | Feb 9, 2017 | Issued |
Array
(
[id] => 15294279
[patent_doc_number] => 20190390275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => CHRONIC KIDNEY DISEASE DIAGNOSTIC
[patent_app_type] => utility
[patent_app_number] => 16/069668
[patent_app_country] => US
[patent_app_date] => 2017-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6571
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16069668
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/069668 | CHRONIC KIDNEY DISEASE DIAGNOSTIC | Jan 25, 2017 | Abandoned |
Array
(
[id] => 11604460
[patent_doc_number] => 20170121760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'PRIMER AND PROBE FOR DETECTION OF MYCOBACTERIUM AVIUM AND METHOD FOR DETECTION OF MYCOBACTERIUM AVIUM BY USING THE PRIMER OR PROBE'
[patent_app_type] => utility
[patent_app_number] => 15/386409
[patent_app_country] => US
[patent_app_date] => 2016-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 41745
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15386409
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/386409 | PRIMER AND PROBE FOR DETECTION OF MYCOBACTERIUM AVIUM AND METHOD FOR DETECTION OF MYCOBACTERIUM AVIUM BY USING THE PRIMER OR PROBE | Dec 20, 2016 | Abandoned |
Array
(
[id] => 11514634
[patent_doc_number] => 20170081708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-23
[patent_title] => 'METHODS OF DIAGNOSING INCREASED RISK OF DEVELOPING MRSA'
[patent_app_type] => utility
[patent_app_number] => 15/367776
[patent_app_country] => US
[patent_app_date] => 2016-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14831
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15367776
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/367776 | METHODS OF DIAGNOSING INCREASED RISK OF DEVELOPING MRSA | Dec 1, 2016 | Abandoned |
Array
(
[id] => 11443604
[patent_doc_number] => 20170044626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'Methods of Detecting Signatures of Disease or Conditions in Bodily Fluids'
[patent_app_type] => utility
[patent_app_number] => 15/338786
[patent_app_country] => US
[patent_app_date] => 2016-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 20892
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15338786
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/338786 | Methods of detecting signatures of disease or conditions in bodily fluids | Oct 30, 2016 | Issued |